Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 5, 2014, Pages 545-551

  Nielsen, Hans Linde ^a,b   Engberg, Jørgen ^c   Ejlertsen, Tove ^b   Nielsen, Henrik ^a  

^a Department of Infectious Diseases ^*  (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c SLAGELSE HOSPITAL   (Denmark)

Author keywords

Anxiety; Campylobacter concisus; Campylobacter jejuni; Depression; Diarrhea; Gastroenteritis; Irritable bowel syndrome; Psychometric scores

Indexed keywords

ADULT; ANXIETY; ARTICLE; CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; CHILL; CONTROLLED STUDY; DEPRESSION; DIZZINESS; FEMALE; GASTROENTERITIS; HEADACHE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MYALGIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SOMATIZATION; AGED; COMPLICATION; DENMARK; FOLLOW UP; IRRITABLE BOWEL SYNDROME; MICROBIOLOGY; MIDDLE AGED; PSYCHOLOGY;

ADULT; AGED; ANXIETY; CAMPYLOBACTER INFECTIONS; CHILLS; DENMARK; DEPRESSION; DIZZINESS; FEMALE; FOLLOW-UP STUDIES; GASTROENTERITIS; HEADACHE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; MYALGIA; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS;

EID: 84898963132     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.886718     Document Type: Article

References (33)

1. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009;136:1979-88
2. Gilkin RJ Jr. The spectrum of irritable bowel syndrome: A clinical review. Clin Ther 2005;27:1696-709
3. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003;98:1578-83. (Pubitemid 36875351
4. Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins SM. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010;59:605-11
5. Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003; 125:1651-9. (Pubitemid 37500429
6. Thornley JP, Jenkins D, Neal K, Wright T, Brough J, Spiller RC. Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis 2001;184:606-9. (Pubitemid 32783552
7. Spence MJ, Moss-Morris R. The cognitive behavioural model of irritable bowel syndrome: A prospective investigation of patients with gastroenteritis. Gut 2007;56:1066-71. (Pubitemid 47123235
8. Schwille-Kiuntke J, Enck P, Zendler C, Krieg M, Polster AV, Klosterhalfen S, et al. Postinfectious irritable bowel syndrome: Follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil 2011;23:e479-88
9. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: A six year follow up study. Gut 2002;51:410-13
10. Gwee KA, Graham JC, McKendrick MW, Collins SM, Marshall JS, Walters SJ, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhea. Lancet 1996;347:150-3. (Pubitemid 26025154
11. Zhang L, Budiman V, Day AS, Mitchell H, Lemberg DA, Riordan SM, et al. Isolation and detection of Campylobacter concisus from saliva of healthy individuals and patients with inflammatory bowel disease. J Clin Microbiol 2010;48: 2965-7
12. Kaakoush NO, Mitchell HM. Campylobacter concisus-A new player in intestinal disease. Front Cell Infect Microbiol 2012;2:4
13. Nielsen HL, Nielsen H, Ejlertsen T, Engberg J, Günzel D, Zeitz M, et al. Oral and fecal Campylobacter concisus strains perturb barrier function by apoptosis induction in HT-29/ B6 intestinal epithelial cells. PLoS One 2011;6:e23858
14. Man SM, Kaakoush NO, Leach ST, Nahidi L, Lu HK, Norman J, et al. Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J Infect Dis 2010;202:1855-65
15. Kalischuk LD, Inglis GD. Comparative genotypic and pathogenic examination of Campylobacter concisus isolates from diarrheic and non-Diarrheic humans. BMC Microbiol 2011; 11:53
16. Ismail Y, Mahendran V, Octavia S, Day AS, Riordan SM, Grimm MC, et al. Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease. PLoS One 2012;7:e38217
17. Zhang L, Man SM, Day AS, Leach ST, Lemberg DA, Dutt S, et al. Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol 2009;47:453-5
18. Mukhopadhya I, Thomson JM, Hansen R, Berry SH, El-Omar EM, Hold GL. Detection of Campylobacter concisus and other campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS One 2011;6: E21490
19. Mahendran V, Riordan SM, Grimm MC, Tran TA, Major J, Kaakoush NO, et al. Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS One 2011;6:e25417
20. Nielsen HL, Ejlertsen T, Engberg J, Nielsen H. High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: A population-based study. Clin Microbiol Infect 2013;19:445-50
21. NielsenHL, Engberg J, EjlertsenT, BückerR, NielsenH.Shortterm and medium-Term clinical outcomes of Campylobacter concisus infection. Clin Microbiol Infect 2012;18:E459-65
22. Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. Clinical manifestations of Campylobacter concisus infection in children. Pediatr Infect Dis J 2013;32:1194-8
23. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. (Pubitemid 13098606
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40: 373-83. (Pubitemid 17055592
25. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159: 702-6. (Pubitemid 38405384
26. Tornblom H, Holmvall P, Svenungsson B, Lindberg G. Gastrointestinal symptoms after infectious diarrhea: A fiveyear follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol 2007;5:461-4. (Pubitemid 46575368
27. Borgaonkar MR, Ford DC, Marshall JK, Churchill E, Collins SM. The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection. Dig Dis Sci 2006;51:1026-32. (Pubitemid 44030833
28. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients. BMJ 1997;314:779-82. (Pubitemid 27117047
29. Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. Evaluation of fecal calprotectin in Campylobacter concisus and Campylobacter jejuni/coli gastroenteritis. Scand J Gastroenterol 2013; 48:633-5
30. Sorensen NB, Nielsen HL, Varming K, Nielsen H. Neutrophil activation by Campylobacter concisus. Gut Pathog 2013; 5:17
31. Moss-Morris R, Spence M. To lump or to split the functional somatic syndromes: Can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome?. Psychosom Med 2006;68:463-9
32. Stermer E, Lubezky A, Potasman I, Paster E, Lavy A. Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome?. A prospective study. Clin Infect Dis 2006;43:898-901. (Pubitemid 44435519
33. Barbara G, Stanghellini V, Berti-Ceroni C, De Giorgio R, Salvioli B, Corradi F, et al. Role of antibiotic therapy on longterm germ excretion in faeces and digestive symptoms after Salmonella infection. Aliment Pharmacol Ther 2000;14: 1127-31